[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Small Nucleic Acid Drug Market Growth 2022-2028

December 2022 | 98 pages | ID: GD2EB110F8A1EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The global market for Small Nucleic Acid Drug is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Small Nucleic Acid Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Small Nucleic Acid Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Small Nucleic Acid Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Small Nucleic Acid Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Small Nucleic Acid Drug players cover Ionis Pharmaceuticals, Sarepta Therapeutics, Alnylam Pharmaceuticals, Biogen and Nippon Shinyaku. etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage

This latest report provides a deep insight into the global Small Nucleic Acid Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Small Nucleic Acid Drug market, with both quantitative and qualitative data, to help readers understand how the Small Nucleic Acid Drug market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

Market Segmentation:

The study segments the Small Nucleic Acid Drug market and forecasts the market size by Type (siRNA Drug and ASO Drug,), by Application (Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Cancer and Others), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
  • siRNA Drug
  • ASO Drug
Segmentation by application
  • Duchenne Muscular Dystrophy
  • Spinal Muscular Atrophy
  • Cancer
  • Others
Segmentation by region
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
Major companies covered
  • Ionis Pharmaceuticals
  • Sarepta Therapeutics
  • Alnylam Pharmaceuticals
  • Biogen
  • Nippon Shinyaku
Chapter Introduction

Chapter 1: Scope of Small Nucleic Acid Drug, Research Methodology, etc.

Chapter 2: Executive Summary, global Small Nucleic Acid Drug market size (sales and revenue) and CAGR, Small Nucleic Acid Drug market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.

Chapter 3: Small Nucleic Acid Drug sales, revenue, average price, global market share, and industry ranking by company, 2017-2022

Chapter 4: Global Small Nucleic Acid Drug sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.

Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.

Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace

Chapter 10: Manufacturing cost structure analysis

Chapter 11: Sales channel, distributors, and customers

Chapter 12: Global Small Nucleic Acid Drug market size forecast by region, by country, by type, and application.

Chapter 13: Comprehensive company profiles of the leading players, including Ionis Pharmaceuticals, Sarepta Therapeutics, Alnylam Pharmaceuticals, Biogen and Nippon Shinyaku, etc.

Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Small Nucleic Acid Drug Annual Sales 2017-2028
  2.1.2 World Current & Future Analysis for Small Nucleic Acid Drug by Geographic Region, 2017, 2022 & 2028
  2.1.3 World Current & Future Analysis for Small Nucleic Acid Drug by Country/Region, 2017, 2022 & 2028
2.2 Small Nucleic Acid Drug Segment by Type
  2.2.1 siRNA Drug
  2.2.2 ASO Drug
2.3 Small Nucleic Acid Drug Sales by Type
  2.3.1 Global Small Nucleic Acid Drug Sales Market Share by Type (2017-2022)
  2.3.2 Global Small Nucleic Acid Drug Revenue and Market Share by Type (2017-2022)
  2.3.3 Global Small Nucleic Acid Drug Sale Price by Type (2017-2022)
2.4 Small Nucleic Acid Drug Segment by Application
  2.4.1 Duchenne Muscular Dystrophy
  2.4.2 Spinal Muscular Atrophy
  2.4.3 Cancer
  2.4.4 Others
2.5 Small Nucleic Acid Drug Sales by Application
  2.5.1 Global Small Nucleic Acid Drug Sale Market Share by Application (2017-2022)
  2.5.2 Global Small Nucleic Acid Drug Revenue and Market Share by Application (2017-2022)
  2.5.3 Global Small Nucleic Acid Drug Sale Price by Application (2017-2022)

3 GLOBAL SMALL NUCLEIC ACID DRUG BY COMPANY

3.1 Global Small Nucleic Acid Drug Breakdown Data by Company
  3.1.1 Global Small Nucleic Acid Drug Annual Sales by Company (2020-2022)
  3.1.2 Global Small Nucleic Acid Drug Sales Market Share by Company (2020-2022)
3.2 Global Small Nucleic Acid Drug Annual Revenue by Company (2020-2022)
  3.2.1 Global Small Nucleic Acid Drug Revenue by Company (2020-2022)
  3.2.2 Global Small Nucleic Acid Drug Revenue Market Share by Company (2020-2022)
3.3 Global Small Nucleic Acid Drug Sale Price by Company
3.4 Key Manufacturers Small Nucleic Acid Drug Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Small Nucleic Acid Drug Product Location Distribution
  3.4.2 Players Small Nucleic Acid Drug Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR SMALL NUCLEIC ACID DRUG BY GEOGRAPHIC REGION

4.1 World Historic Small Nucleic Acid Drug Market Size by Geographic Region (2017-2022)
  4.1.1 Global Small Nucleic Acid Drug Annual Sales by Geographic Region (2017-2022)
  4.1.2 Global Small Nucleic Acid Drug Annual Revenue by Geographic Region
4.2 World Historic Small Nucleic Acid Drug Market Size by Country/Region (2017-2022)
  4.2.1 Global Small Nucleic Acid Drug Annual Sales by Country/Region (2017-2022)
  4.2.2 Global Small Nucleic Acid Drug Annual Revenue by Country/Region
4.3 Americas Small Nucleic Acid Drug Sales Growth
4.4 APAC Small Nucleic Acid Drug Sales Growth
4.5 Europe Small Nucleic Acid Drug Sales Growth
4.6 Middle East & Africa Small Nucleic Acid Drug Sales Growth

5 AMERICAS

5.1 Americas Small Nucleic Acid Drug Sales by Country
  5.1.1 Americas Small Nucleic Acid Drug Sales by Country (2017-2022)
  5.1.2 Americas Small Nucleic Acid Drug Revenue by Country (2017-2022)
5.2 Americas Small Nucleic Acid Drug Sales by Type
5.3 Americas Small Nucleic Acid Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Small Nucleic Acid Drug Sales by Region
  6.1.1 APAC Small Nucleic Acid Drug Sales by Region (2017-2022)
  6.1.2 APAC Small Nucleic Acid Drug Revenue by Region (2017-2022)
6.2 APAC Small Nucleic Acid Drug Sales by Type
6.3 APAC Small Nucleic Acid Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Small Nucleic Acid Drug by Country
  7.1.1 Europe Small Nucleic Acid Drug Sales by Country (2017-2022)
  7.1.2 Europe Small Nucleic Acid Drug Revenue by Country (2017-2022)
7.2 Europe Small Nucleic Acid Drug Sales by Type
7.3 Europe Small Nucleic Acid Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Small Nucleic Acid Drug by Country
  8.1.1 Middle East & Africa Small Nucleic Acid Drug Sales by Country (2017-2022)
  8.1.2 Middle East & Africa Small Nucleic Acid Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Small Nucleic Acid Drug Sales by Type
8.3 Middle East & Africa Small Nucleic Acid Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Small Nucleic Acid Drug
10.3 Manufacturing Process Analysis of Small Nucleic Acid Drug
10.4 Industry Chain Structure of Small Nucleic Acid Drug

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Small Nucleic Acid Drug Distributors
11.3 Small Nucleic Acid Drug Customer

12 WORLD FORECAST REVIEW FOR SMALL NUCLEIC ACID DRUG BY GEOGRAPHIC REGION

12.1 Global Small Nucleic Acid Drug Market Size Forecast by Region
  12.1.1 Global Small Nucleic Acid Drug Forecast by Region (2023-2028)
  12.1.2 Global Small Nucleic Acid Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Small Nucleic Acid Drug Forecast by Type
12.7 Global Small Nucleic Acid Drug Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Ionis Pharmaceuticals
  13.1.1 Ionis Pharmaceuticals Company Information
  13.1.2 Ionis Pharmaceuticals Small Nucleic Acid Drug Product Offered
  13.1.3 Ionis Pharmaceuticals Small Nucleic Acid Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  13.1.4 Ionis Pharmaceuticals Main Business Overview
  13.1.5 Ionis Pharmaceuticals Latest Developments
13.2 Sarepta Therapeutics
  13.2.1 Sarepta Therapeutics Company Information
  13.2.2 Sarepta Therapeutics Small Nucleic Acid Drug Product Offered
  13.2.3 Sarepta Therapeutics Small Nucleic Acid Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  13.2.4 Sarepta Therapeutics Main Business Overview
  13.2.5 Sarepta Therapeutics Latest Developments
13.3 Alnylam Pharmaceuticals
  13.3.1 Alnylam Pharmaceuticals Company Information
  13.3.2 Alnylam Pharmaceuticals Small Nucleic Acid Drug Product Offered
  13.3.3 Alnylam Pharmaceuticals Small Nucleic Acid Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  13.3.4 Alnylam Pharmaceuticals Main Business Overview
  13.3.5 Alnylam Pharmaceuticals Latest Developments
13.4 Biogen
  13.4.1 Biogen Company Information
  13.4.2 Biogen Small Nucleic Acid Drug Product Offered
  13.4.3 Biogen Small Nucleic Acid Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  13.4.4 Biogen Main Business Overview
  13.4.5 Biogen Latest Developments
13.5 Nippon Shinyaku
  13.5.1 Nippon Shinyaku Company Information
  13.5.2 Nippon Shinyaku Small Nucleic Acid Drug Product Offered
  13.5.3 Nippon Shinyaku Small Nucleic Acid Drug Sales, Revenue, Price and Gross Margin (2020-2022)
  13.5.4 Nippon Shinyaku Main Business Overview
  13.5.5 Nippon Shinyaku Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Small Nucleic Acid Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Small Nucleic Acid Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of siRNA Drug
Table 4. Major Players of ASO Drug
Table 5. Global Small Nucleic Acid Drug Sales by Type (2017-2022) & (K Units)
Table 6. Global Small Nucleic Acid Drug Sales Market Share by Type (2017-2022)
Table 7. Global Small Nucleic Acid Drug Revenue by Type (2017-2022) & ($ million)
Table 8. Global Small Nucleic Acid Drug Revenue Market Share by Type (2017-2022)
Table 9. Global Small Nucleic Acid Drug Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Small Nucleic Acid Drug Sales by Application (2017-2022) & (K Units)
Table 11. Global Small Nucleic Acid Drug Sales Market Share by Application (2017-2022)
Table 12. Global Small Nucleic Acid Drug Revenue by Application (2017-2022)
Table 13. Global Small Nucleic Acid Drug Revenue Market Share by Application (2017-2022)
Table 14. Global Small Nucleic Acid Drug Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Small Nucleic Acid Drug Sales by Company (2020-2022) & (K Units)
Table 16. Global Small Nucleic Acid Drug Sales Market Share by Company (2020-2022)
Table 17. Global Small Nucleic Acid Drug Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Small Nucleic Acid Drug Revenue Market Share by Company (2020-2022)
Table 19. Global Small Nucleic Acid Drug Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Small Nucleic Acid Drug Producing Area Distribution and Sales Area
Table 21. Players Small Nucleic Acid Drug Products Offered
Table 22. Small Nucleic Acid Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Small Nucleic Acid Drug Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Small Nucleic Acid Drug Sales Market Share Geographic Region (2017-2022)
Table 27. Global Small Nucleic Acid Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Small Nucleic Acid Drug Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Small Nucleic Acid Drug Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Small Nucleic Acid Drug Sales Market Share by Country/Region (2017-2022)
Table 31. Global Small Nucleic Acid Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Small Nucleic Acid Drug Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Small Nucleic Acid Drug Sales by Country (2017-2022) & (K Units)
Table 34. Americas Small Nucleic Acid Drug Sales Market Share by Country (2017-2022)
Table 35. Americas Small Nucleic Acid Drug Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Small Nucleic Acid Drug Revenue Market Share by Country (2017-2022)
Table 37. Americas Small Nucleic Acid Drug Sales by Type (2017-2022) & (K Units)
Table 38. Americas Small Nucleic Acid Drug Sales Market Share by Type (2017-2022)
Table 39. Americas Small Nucleic Acid Drug Sales by Application (2017-2022) & (K Units)
Table 40. Americas Small Nucleic Acid Drug Sales Market Share by Application (2017-2022)
Table 41. APAC Small Nucleic Acid Drug Sales by Region (2017-2022) & (K Units)
Table 42. APAC Small Nucleic Acid Drug Sales Market Share by Region (2017-2022)
Table 43. APAC Small Nucleic Acid Drug Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Small Nucleic Acid Drug Revenue Market Share by Region (2017-2022)
Table 45. APAC Small Nucleic Acid Drug Sales by Type (2017-2022) & (K Units)
Table 46. APAC Small Nucleic Acid Drug Sales Market Share by Type (2017-2022)
Table 47. APAC Small Nucleic Acid Drug Sales by Application (2017-2022) & (K Units)
Table 48. APAC Small Nucleic Acid Drug Sales Market Share by Application (2017-2022)
Table 49. Europe Small Nucleic Acid Drug Sales by Country (2017-2022) & (K Units)
Table 50. Europe Small Nucleic Acid Drug Sales Market Share by Country (2017-2022)
Table 51. Europe Small Nucleic Acid Drug Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Small Nucleic Acid Drug Revenue Market Share by Country (2017-2022)
Table 53. Europe Small Nucleic Acid Drug Sales by Type (2017-2022) & (K Units)
Table 54. Europe Small Nucleic Acid Drug Sales Market Share by Type (2017-2022)
Table 55. Europe Small Nucleic Acid Drug Sales by Application (2017-2022) & (K Units)
Table 56. Europe Small Nucleic Acid Drug Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Small Nucleic Acid Drug Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Small Nucleic Acid Drug Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Small Nucleic Acid Drug Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Small Nucleic Acid Drug Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Small Nucleic Acid Drug Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Small Nucleic Acid Drug Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Small Nucleic Acid Drug Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Small Nucleic Acid Drug Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Small Nucleic Acid Drug
Table 66. Key Market Challenges & Risks of Small Nucleic Acid Drug
Table 67. Key Industry Trends of Small Nucleic Acid Drug
Table 68. Small Nucleic Acid Drug Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Small Nucleic Acid Drug Distributors List
Table 71. Small Nucleic Acid Drug Customer List
Table 72. Global Small Nucleic Acid Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Small Nucleic Acid Drug Sales Market Forecast by Region
Table 74. Global Small Nucleic Acid Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Small Nucleic Acid Drug Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Small Nucleic Acid Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Small Nucleic Acid Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Small Nucleic Acid Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Small Nucleic Acid Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Small Nucleic Acid Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Small Nucleic Acid Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Small Nucleic Acid Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Small Nucleic Acid Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Small Nucleic Acid Drug Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Small Nucleic Acid Drug Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Small Nucleic Acid Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Small Nucleic Acid Drug Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Small Nucleic Acid Drug Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Small Nucleic Acid Drug Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Small Nucleic Acid Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Small Nucleic Acid Drug Revenue Market Share Forecast by Application (2023-2028)
Table 92. Ionis Pharmaceuticals Basic Information, Small Nucleic Acid Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. Ionis Pharmaceuticals Small Nucleic Acid Drug Product Offered
Table 94. Ionis Pharmaceuticals Small Nucleic Acid Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Ionis Pharmaceuticals Main Business
Table 96. Ionis Pharmaceuticals Latest Developments
Table 97. Sarepta Therapeutics Basic Information, Small Nucleic Acid Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. Sarepta Therapeutics Small Nucleic Acid Drug Product Offered
Table 99. Sarepta Therapeutics Small Nucleic Acid Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Sarepta Therapeutics Main Business
Table 101. Sarepta Therapeutics Latest Developments
Table 102. Alnylam Pharmaceuticals Basic Information, Small Nucleic Acid Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. Alnylam Pharmaceuticals Small Nucleic Acid Drug Product Offered
Table 104. Alnylam Pharmaceuticals Small Nucleic Acid Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Alnylam Pharmaceuticals Main Business
Table 106. Alnylam Pharmaceuticals Latest Developments
Table 107. Biogen Basic Information, Small Nucleic Acid Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Biogen Small Nucleic Acid Drug Product Offered
Table 109. Biogen Small Nucleic Acid Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Biogen Main Business
Table 111. Biogen Latest Developments
Table 112. Nippon Shinyaku Basic Information, Small Nucleic Acid Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. Nippon Shinyaku Small Nucleic Acid Drug Product Offered
Table 114. Nippon Shinyaku Small Nucleic Acid Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Nippon Shinyaku Main Business
Table 116. Nippon Shinyaku Latest Developments

LIST OF FIGURES

Figure 1. Picture of Small Nucleic Acid Drug
Figure 2. Small Nucleic Acid Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Small Nucleic Acid Drug Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Small Nucleic Acid Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Small Nucleic Acid Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of siRNA Drug
Figure 10. Product Picture of ASO Drug
Figure 11. Global Small Nucleic Acid Drug Sales Market Share by Type in 2021
Figure 12. Global Small Nucleic Acid Drug Revenue Market Share by Type (2017-2022)
Figure 13. Small Nucleic Acid Drug Consumed in Duchenne Muscular Dystrophy
Figure 14. Global Small Nucleic Acid Drug Market: Duchenne Muscular Dystrophy (2017-2022) & (K Units)
Figure 15. Small Nucleic Acid Drug Consumed in Spinal Muscular Atrophy
Figure 16. Global Small Nucleic Acid Drug Market: Spinal Muscular Atrophy (2017-2022) & (K Units)
Figure 17. Small Nucleic Acid Drug Consumed in Cancer
Figure 18. Global Small Nucleic Acid Drug Market: Cancer (2017-2022) & (K Units)
Figure 19. Small Nucleic Acid Drug Consumed in Others
Figure 20. Global Small Nucleic Acid Drug Market: Others (2017-2022) & (K Units)
Figure 21. Global Small Nucleic Acid Drug Sales Market Share by Application (2017-2022)
Figure 22. Global Small Nucleic Acid Drug Revenue Market Share by Application in 2021
Figure 23. Small Nucleic Acid Drug Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Small Nucleic Acid Drug Revenue Market Share by Company in 2021
Figure 25. Global Small Nucleic Acid Drug Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Small Nucleic Acid Drug Revenue Market Share by Geographic Region in 2021
Figure 27. Global Small Nucleic Acid Drug Sales Market Share by Region (2017-2022)
Figure 28. Global Small Nucleic Acid Drug Revenue Market Share by Country/Region in 2021
Figure 29. Americas Small Nucleic Acid Drug Sales 2017-2022 (K Units)
Figure 30. Americas Small Nucleic Acid Drug Revenue 2017-2022 ($ Millions)
Figure 31. APAC Small Nucleic Acid Drug Sales 2017-2022 (K Units)
Figure 32. APAC Small Nucleic Acid Drug Revenue 2017-2022 ($ Millions)
Figure 33. Europe Small Nucleic Acid Drug Sales 2017-2022 (K Units)
Figure 34. Europe Small Nucleic Acid Drug Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Small Nucleic Acid Drug Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Small Nucleic Acid Drug Revenue 2017-2022 ($ Millions)
Figure 37. Americas Small Nucleic Acid Drug Sales Market Share by Country in 2021
Figure 38. Americas Small Nucleic Acid Drug Revenue Market Share by Country in 2021
Figure 39. United States Small Nucleic Acid Drug Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Small Nucleic Acid Drug Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Small Nucleic Acid Drug Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Small Nucleic Acid Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Small Nucleic Acid Drug Sales Market Share by Region in 2021
Figure 44. APAC Small Nucleic Acid Drug Revenue Market Share by Regions in 2021
Figure 45. China Small Nucleic Acid Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Small Nucleic Acid Drug Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Small Nucleic Acid Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Small Nucleic Acid Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Small Nucleic Acid Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Small Nucleic Acid Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Small Nucleic Acid Drug Sales Market Share by Country in 2021
Figure 52. Europe Small Nucleic Acid Drug Revenue Market Share by Country in 2021
Figure 53. Germany Small Nucleic Acid Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Small Nucleic Acid Drug Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Small Nucleic Acid Drug Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Small Nucleic Acid Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Small Nucleic Acid Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Small Nucleic Acid Drug Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Small Nucleic Acid Drug Revenue Market Share by Country in 2021
Figure 60. Egypt Small Nucleic Acid Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Small Nucleic Acid Drug Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Small Nucleic Acid Drug Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Small Nucleic Acid Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Small Nucleic Acid Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Small Nucleic Acid Drug in 2021
Figure 66. Manufacturing Process Analysis of Small Nucleic Acid Drug
Figure 67. Industry Chain Structure of Small Nucleic Acid Drug
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles


More Publications